Terms: = Lymphoma AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2 AND Prognosis
6482 results:
1. [Clinical Features and Prognostic Analysis of Newly Diagnosed Diffuse Large B-cell lymphoma Combined with Hemophagocytic Syndrome].
Wei XF; Feng YF; Fu Y; Liu F; Chen QL; Zhang QK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):466-469. PubMed ID: 38660853
[TBL] [Abstract] [Full Text] [Related]
2. [Correlation Analysis of Peripheral Blood B Cell Count with Clinical Features and prognosis in Patients Newly Diagnosed with Diffuse Large B-Cell lymphoma].
Lu T; Mi H; Zhao DD; Yang SG; Bu YW; Zhang F; Chen WM; Sun DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):458-465. PubMed ID: 38660852
[TBL] [Abstract] [Full Text] [Related]
3. [Expression of CD30 in Patients with Diffuse Large B-Cell lymphoma and Clinical Significance].
Qu Y; Lu XZ; Wang RX; Hei XF; Li J; Xiao BT; Jia ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):450-457. PubMed ID: 38660851
[TBL] [Abstract] [Full Text] [Related]
4. [A Real-World Single-Center Study of Adult Hodgkin's lymphoma].
Wang LL; Tian L; Dong F; Yang P; Wan W; Li QH; Ma L; Gao JJ; Wang JJ; Zhao W; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):428-433. PubMed ID: 38660847
[TBL] [Abstract] [Full Text] [Related]
5. Outcomes of the transformation of follicular lymphoma to diffuse large B-cell lymphoma in the rituximab era: A population-based study.
Zheng W; Liu M; Guan L; Wang S
Cancer Med; 2024 Apr; 13(8):e7120. PubMed ID: 38629251
[TBL] [Abstract] [Full Text] [Related]
6. MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases.
Zhang LF; Zhang Y; Shui RH; Lu HF; Jiang WH; Cai X; Li XQ; Yu BH
Diagn Pathol; 2024 Apr; 19(1):60. PubMed ID: 38627702
[TBL] [Abstract] [Full Text] [Related]
7. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma.
Chen J; Zhou J; Cheng F; Chen D; Guan F; Zhang E; He J; Cai Z; Zhao Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):181. PubMed ID: 38587664
[TBL] [Abstract] [Full Text] [Related]
8. Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies.
Giudice V; Ianniello M; De Novellis D; Pezzullo L; Petrillo N; Serio B; D'Addona M; Della Corte AM; Rizzo M; Cuffa B; Castaldi MA; Savarese P; Mori A; Castiello R; Fico A; Savarese G; Selleri C
Clin Exp Med; 2024 Apr; 24(1):69. PubMed ID: 38578383
[TBL] [Abstract] [Full Text] [Related]
9. Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1.
Li J; Ma X; Xu F; Yan Y; Chen W
Pharm Biol; 2024 Dec; 62(1):314-325. PubMed ID: 38571483
[TBL] [Abstract] [Full Text] [Related]
10. The RAS-signaling-pathway-mutation-related prognosis in B-cell acute lymphoblastic leukemia: A report from South China children's leukemia group.
Li X; Lin S; Liao N; Mai H; Long X; Liu L; Wu B; Chen Q; Kong Q; Kong X; Liu L; Qin J; Fang J; Zhou D
Hematol Oncol; 2024 May; 42(3):e3265. PubMed ID: 38564328
[TBL] [Abstract] [Full Text] [Related]
11. Clinical features of intussusception in children secondary to small bowel tumours: a retrospective study of 31 cases.
Wang L; Zhang H; Wang D; Shen Q; Huang L; Liu T
BMC Pediatr; 2024 Apr; 24(1):227. PubMed ID: 38561715
[TBL] [Abstract] [Full Text] [Related]
12. Clinical and histopathological spectrum of cranial small round cell tumors: An experience from a tertiary care center.
Gupta P; Siraj F; Shankar KB; Rawat M; Mankotia DS; Yadav V; Dagar A
J Cancer Res Ther; 2024 Jan; 20(1):238-242. PubMed ID: 38554327
[TBL] [Abstract] [Full Text] [Related]
13. Development and validation of a novel prognostic nomogram for advanced diffuse large B cell lymphoma.
Wan M; Zhang W; Huang H; Fang X; Chen Y; Tian Y; Yao Y; Weng H; Chen Z; Yu L; Tian Y; Huang H; Li X; Hong H; Lin T
Clin Exp Med; 2024 Mar; 24(1):64. PubMed ID: 38554186
[TBL] [Abstract] [Full Text] [Related]
14. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
Wu LX; Zhao MY; Yan N; Zhou YL; Cao LM; Qin YZ; Jiang Q; Xu LP; Zhang XH; Huang XJ; Jiang H; Ruan GR
Clin Exp Med; 2024 Mar; 24(1):56. PubMed ID: 38546916
[TBL] [Abstract] [Full Text] [Related]
15. The potential value of ultrasound in predicting local refractory/relapse events in primary thyroid lymphoma patients.
Ji J; Gao L; Liu R; Shi X; Ma L; Pan A; Li N; Liu C; Li X; Yang M; Xia Y; Jiang Y
Cancer Imaging; 2024 Mar; 24(1):39. PubMed ID: 38509603
[TBL] [Abstract] [Full Text] [Related]
16. Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing.
Jeon MJ; Yu ES; Kim DS; Choi CW; Kim HN; Kwon JA; Yoon SY; Yoon J
J Clin Lab Anal; 2024 Mar; 38(6):e25027. PubMed ID: 38506403
[TBL] [Abstract] [Full Text] [Related]
17. Survival Outcome and Prognostic Factors of Primary Spinal Cord lymphoma.
Qianjin D; Zhenguo C; Yang W; Baoshun D; Laiguang S
Turk Neurosurg; 2024; 34(2):216-223. PubMed ID: 38497173
[TBL] [Abstract] [Full Text] [Related]
18. Global burden, risk factors, and trends of non-Hodgkin lymphoma: A worldwide analysis of cancer registries.
Huang J; Chan SC; Lok V; Zhang L; Lucero-Prisno DE; Xu W; Zheng ZJ; Elcarte E; Withers M; Wong MCS
Cancer Med; 2024 Mar; 13(5):e7056. PubMed ID: 38477498
[TBL] [Abstract] [Full Text] [Related]
19. The RNA sequencing results revealed the expression of different genes and signaling pathways during chemotherapy resistance in peripheral T-cell lymphoma.
Lan Y; Tao W; Ma L; Wang X; Li H; Du Y; Yang R; Wu S; Ou Y; Liu X; Huang Y; Zhou Y
BMC Med Genomics; 2024 Mar; 17(1):74. PubMed ID: 38468267
[TBL] [Abstract] [Full Text] [Related]
20. Incidence and survival of second primary non-Hodgkin lymphoma: A Surveillance, Epidemiology, and End Results-based cohort study.
Yu N; Zhang W; Zhong X; Song X; Li W
PLoS One; 2024; 19(3):e0300330. PubMed ID: 38466704
[TBL] [Abstract] [Full Text] [Related]
[Next]
